This document is from our Archive and no action should be taken in reliance on it without specific legal advice. You can perform a search for more recent content.
One of the sectors particularly affected by Brexit is the life sciences industry. Notwithstanding the additional regulatory demands of COVID-19, the MHRA has produced a series of guidance documents, some still in consultation form, setting out the framework for how medicines and medical devices will be regulated.